These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 35237659)
1. Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer. Liu L; Huang L; Chen W; Zhang G; Li Y; Wu Y; Xiong J; Jie Z Front Mol Biosci; 2022; 9():811269. PubMed ID: 35237659 [TBL] [Abstract][Full Text] [Related]
2. The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer. Liu L; Wu Y; Chen W; Li Y; Yu J; Zhang G; Fu P; Huang L; Xiong J; Jie Z Front Genet; 2022; 13():892589. PubMed ID: 35846130 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma. Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355 [TBL] [Abstract][Full Text] [Related]
4. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer. Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X Front Genet; 2022; 13():984696. PubMed ID: 36092933 [No Abstract] [Full Text] [Related]
5. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma. Tang H; Chen H; Yuan H; Jin X; Chen G Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185 [TBL] [Abstract][Full Text] [Related]
7. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients. Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B Front Genet; 2022; 13():966896. PubMed ID: 36186456 [No Abstract] [Full Text] [Related]
8. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
9. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976 [No Abstract] [Full Text] [Related]
10. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer. Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919 [TBL] [Abstract][Full Text] [Related]
11. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S Front Genet; 2022; 13():862741. PubMed ID: 35368663 [No Abstract] [Full Text] [Related]
12. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA. Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900 [TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma. Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A Front Genet; 2022; 13():916024. PubMed ID: 36110223 [No Abstract] [Full Text] [Related]
14. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
15. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma. Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Pyroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients with Colon Cancer. Liu L; Chen W; Li Y; Fu P; Cao Y; Li Z; Xiong J; Jie Z J Oncol; 2022; 2022():2035808. PubMed ID: 35087586 [TBL] [Abstract][Full Text] [Related]
17. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors. Li H; Lv Z; Liu M Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients. Chen D; Dou C; Liu H; Xu B; Hu B; Kuang L; Yao J; Zhao Y; Yu S; Li Y; Wang F; Guo M Front Oncol; 2022; 12():929233. PubMed ID: 36033536 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X Front Immunol; 2022; 13():1085038. PubMed ID: 36618366 [TBL] [Abstract][Full Text] [Related]
20. Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma. Zhang R; Li Q; Yu X; Hou Y; Yan L; Gao Y; Ji L; Zhang X; Fang M; Huang L; Yu Z; Gao Y; Li M Heliyon; 2023 Nov; 9(11):e22083. PubMed ID: 38034714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]